Skip to main content
Publish date:

Teva Plans Buyback

$600 million worth.


(TEVA) - Get Teva Pharmaceutical Industries Limited Sponsored ADR Report

plans a buyback of $600 million in stock.

The Israel-based pharmaceuticals company's shares were down $1.20, or 3.6%, at $32.10 Tuesday.

TheStreet Recommends

This story was created through a joint venture between and IRIS.